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INTRODUCTION
Surgery is considered the corner stone for management 
of chest wall malignancy.1–3 The wide resection resulting in 
large chest wall defects can lead to instability, interference 
with respiration with the potential increase in postopera-
tive morbidity and mortality.4,5 The principles of chest wall 
reconstruction are well known, radical resection ensuring 
adequate tumor-free margins, maintenance of chest wall 
stability, lung functional, and acceptable cosmetic results.1,2 
However, the insertion of prosthetic material to achieve 
rigid and nonrigid skeletal reconstruction could be asso-
ciated with more complications including surgical-site in-
fection (SSI), wound dehiscence, and possible extrusion 
of prosthesis especially in high-risk patients.3,6,7 Uni/mul-
tivariate analysis of predictors of complications has been 
previously discussed in the literature including general fac-
tors (diabetes, immune-suppression, morbid obesity, smok-
ing) and local factors (previous radiotherapy and surgery, 
fungating and infected tumors).1,6,8 Various materials have 
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Background: Tenets of chest wall reconstruction for malignancy are well known; 
however, the insertion of synthetic prosthetic material to achieve rigid and nonrig-
id skeletal reconstruction could be associated with more complications including 
infection and extrusion especially in high risk patients. This includes fungating, 
infected tumors, previous radiotherapy, scars, smoking, diabetes, and morbid obe-
sity. Bioprosthesis Acelluar Dermal Matrix Strattice would be a substitute to resist 
infection and provide stable coverage.
Methods: A retrospective data analysis study on 8 high-risk patients who underwent 
chest wall resection and reconstruction with bioprosthesis (Strattice) with/without 
titanium plates in the period between 2012 and 2017 was performed. Patient’s 
demographics, risk factors, clinico-pathological, radiological, operative details, ad-
juvant therapy, postoperative morbidity, and follow-up data were recorded.
Results: Sarcoma was the pathology in 7 and recurrent breast cancer in 1 with age range 
from 21 to 71 years (mean, 50) and preponderance of female patients (n = 5). Defects 
were located anterior/anterolateral with size ranging from 270 to 1,050 cm2 (mean, 
511). Reconstruction was performed using Strattice only in 4 patients, whereas in 4 it 
was combined with titanium plates. All patients required flap reconstruction (3 pedi-
cled and 5 free). The follow-up ranged from 9 to 52 months (mean, 24.8). Minor com-
plications occurred in 2 patients; however, good functional outcome was achieved in all.
Conclusion: Strattice would act as a safe alternative modality for chest wall recon-
struction to resist infection in high-risk patients with extensive defects. It should be 
considered as a valuable tool in the armamentarium of chest wall reconstruction. 
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been reported to be used for either rigid or nonrigid chest 
wall reconstruction to achieve functional chest wall stability 
including mainly synthetic meshes [Polyprolene (Marlex) 
poly tetrafluoroethylene (Gore-Tex)], Methylmethacrylate 
sandwich mesh, Stratos osteosynthesis system comprising 
titanium bars and clips and other metallic substitutes.3,9–11 
On the other hand, there is sparse evidence reported in 
the literature mainly reported cases on the use of biological 
mesh (Permocal, Alloderm, and Strattice) both in clinical 
practice and animal model.7,12–17 We report our case series 
experience using acelluar dermal matrix (ADM) Strattice 
in patients at increased risks of synthetic prosthetic mesh–
related complications due to mainly local factors including 
infected fungating and necrotic tumors, previous surgery 
and perioperative radiotherapy/chemotherapy and to a 
lesser extent general factors as smoking, morbid obesity, 
and diabetes.
MATERIALS AND METHODS
Prospectively collected data from 8 consecutive cancer 
patients who underwent chest wall resection and recon-
struction with Strattice (ADM) biological mesh in the pe-
riod between January 2012 and April 2017 were reviewed. 
The indication to consider bioprosthetic material Strattice 
included high-risk patients having contamination of the 
operative field (fungating, infected, and necrotic tumors), 
previous local radiotherapy and surgery and/or associated 
general risk factors as diabetes, active smoking, chemo-
therapy, and morbid obesity. All patients were managed 
through a multidisciplinary approach including thoracic 
surgeon (M.K.) and reconstructive surgeon (H.K.) to op-
timize their perioperative treatment plan. This included 
preoperative preparation, pulmonary function test to 
assess fitness, radiological investigations including com-
puted tomographic (CT) scan and/or angiography and 
magnetic resonance imaging to plan the surgical resec-
tion, possible skeletal and soft-tissue reconstructive op-
tions and oncological adjuvant therapy.
Data Collection
A prospectively maintained database was used to iden-
tify the patients, and their records were assessed retro-
spectively. The demographic information and potential 
identifiable risks and comorbidities, previous history of 
malignancy, and treatment were collected. Tumor charac-
teristics and details of adjuvant therapy including either 
chemotherapy or radiotherapy were also documented. 
The results of the radiological diagnostic workup includ-
ed standard chest x-ray, CT scan, and magnetic resonance 
imaging to delineate the extent of the tumor in the chest 
wall, and involvement of adjacent surrounding structures 
was noted. The operative details identified the numbers 
of ribs and costochondral junctions along with other 
structures that were resected as part of the tumor extipira-
tion and included intercostal muscles, chest wall muscles, 
lungs, diaphragm, and overlying soft tissue. The sizes of 
the skeletal and soft-tissue defect were recorded in all pa-
tients. Documentation of whether Strattice was used solely 
or in adjunct with titanium plates and rib clips (Strasbourg 
Thoracic Osteosyntheses System; MedXpert Gmbh, Heit-
ersheim, Germany) to restore chest wall integrity was not-
ed. In addition, the methods of soft-tissue coverage were 
also documented. The postoperative outcomes in terms of 
length of stay, complications particularly SSI, wound de-
hiscence, chest wall stability, and respiratory function were 
identified from the patient records.
Operative Consideration
All patients included were considered for surgery af-
ter been reviewed by the multidisciplinary thoracic onco-
plastic team in the sarcoma and breast multidisciplinary 
team meeting (MDT). The resection and reconstruction 
were performed as a 1-stage procedure in all patients with 
a 2 team approach. In the majority of cases (5/8), the 2 
teams worked simultaneously when free flap reconstruc-
tion was performed, whereas in 2 (2 of 8), the thoracic 
surgeons initially performed the resection and restored 
the skeletal wall integrity; this was followed by harvesting 
and insetting of the selected regional flap. On the other 
hand, in 1 patient, the reconstructive team harvested the 
selected regional flap first to facilitate tumor extipiration 
and also salvage the regional flap from being damaged 
through the conventional thoracic approach. Post tumor 
resection chest wall stability was achieved using firm Strat-
tice ADM (30 × 30 or 15 × 15 cm), which was washed in vitro 
with 5 L of saline to remove any chemical preservatives, 
followed by fashioning of the sheet to the defect (onlay 
technique) and securing it to the surrounding rib edges 
with interrupted Ethibond 2/0 sutures. Titanium plates 
and rib clips (Stratos osteosynthesis MedExpert) were 
used in addition to the Strattice ADM in 4 patients due to 
the extent of the resection and the location of the tumor 
being anterolateral to maintain structural support and sta-
bility. The site, size of the defect, availability of tissues, and 
preference of the reconstructive surgeon determined the 
choice of the soft-tissue flap. Soft-tissue reconstruction was 
achieved utilizing loco-regional pedicled muscle flaps as 
latissimus dorsi with or without split-thickness graft. Free 
microvascular tissue was indicated in more extensive re-
section with large surface area or when loco-regional flaps 
deemed not feasible due to direct tumor involvement, 
vascular compromise, and previous radiotherapy or sur-
gery. We were mindful of creating a suitable window in the 
Strattice sheet in the cases where the internal mammary 
pedicle was used as the recipient pedicle for the free flap 
to avoid any compromise of the vascular supply postmicro-
vascular anastomosis. As a routine, all surgical sites were 
copiously irrigated with pulse-jet lavage using 3 L of saline 
(0.9% Nacl) solution to mechanically remove any debris 
or loose diathermized tissue and to maintain moisture of 
the Strattice. A chest wall tube was placed in the thoracic 
cavity, whereas suction drains were inserted deep into the 
flap and subcutaneous tissue. The duration of the drain-
age depended on the clinical, chest x-ray, and biological 
follow-up. Intraoperative collagen implant impregnated 
with aminoglycoside antibiotic gentamicin (Collatamp, 
EUSA Pharma, Hempstead, UK) was inserted in the op-
erative field before closure. All 8 patients were transferred 
to intensive therapy unit with 6 patients (6 of 8) extubated 
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at the end of surgery and 2 within 12 hours. Standard flap 
observation chart protocol was followed, including Dop-
pler signal, skin color, temperature, and capillary refill. 
At induction, all patients received antibiotics intravenous 
therapy, determined by appropriate tissue penetrability 
with special reference to bone and joint infections for 
prosthetic device18 and continued routinely for 48 hours 
postoperatively followed by oral therapy for the duration 
of time the drains remained in situ. All patients received 
structured physiotherapy and rehabilitation program for 
both chest and donor site depending on flap selection.
RESULTS
The patient, tumor, and chest wall defect characteris-
tics including surgical management and outcomes for the 
cases are summarized in Table 1. The risks for SSI included 
fungating, infected and necrotic tumors, previous local ra-
diotherapy, and surgical scar along with general risk factors 
as diabetes, active smoking, chemotherapy, and morbid 
obesity. The tumor tissue was recurrent breast cancer in 1 
and sarcoma in 7 and with age range from 21 to 71 years 
(mean, 50) and preponderance of female patients (n = 5). 
Resultant defects were located anterior, lateral, and an-
terolateral with sizes ranging from 270 to 1,050 cm2 (mean, 
511).The average number of ribs resected with adjoining 
costochondral cartilage was between 3 and 10 (median, 4). 
In addition, partial sternectomy was performed in 1 patient 
and complete sternal resection in another one. Adequate 
clear surgical resection margins were achieved in all the 
patients. The resultant chest wall defect was repaired us-
ing Strattice in all patients. In 4 patients, the defects were 
large, crossing midline and required additional rigid re-
construction using titanium plates and rib clips (Stratos). 
The repaired defects were covered in all patients with soft-
tissue flaps successfully achieved with free microvascular 
tissue transfer in 5 patients [muscle sparing transverse 
abdominus myocutaneous (MSTRAM) type I (n = 4) and 
tensor fasciae latae (TFL; n = 1)], whereas in 3 pedicled 
latissimus dorsi muscle with split-thickness graft and mus-
culocutaneous flap were performed. The recipient vessels 
for the microvascular anastomosis were internal mammary 
pedicle (n = 4) and thoracodorsal pedicle (n = 1; Figs 1–5; 
see video, Supplemental Digital Content 1, demonstrating 
the multidisciplinary 2-team simultaneous approach for 
enbloc resection of a fungating infected large chondrosar-
coma of the anterior chest wall. This video is available in 
the “Related Videos” section of PRSGlobalOpen.com or at 
http://links.lww.com/PRSGO/A722).
Two patients experienced minor complications, 1 de-
veloped wound breakdown and superficial SSI 10 months 
postoperatively after receiving radiotherapy. This required 
minor surgical debridement with secondary closure. The 
same patient developed local recurrence and distant me-
tastases (month 12 postoperatively) and was referred to 
the palliative team. The other patient developed super-
ficial minor distal flap necrosis, which required debride-
ment and flap readvancement day 14 postoperatively; in 
neither patients, the Strattice was exposed. During the 
follow-up period of 9–52 months (mean, 24.8), there was 
no local recurrence or distant metastases in any of the 
other patients with clinically good chest wall function. No 
readmissions were encountered within the 30 days from 
discharge. One patient died at 14 months due to systemic 
disease progression.
DISCUSSION
The synthetic prosthesis mesh is used in the majority 
of chest wall reconstruction following resection of tumors. 
However, there is an increased risk of SSI, particularly if 
used in compromised surgical fields including fungating 
infected necrotic tumors, previously local radiotherapy 
and surgical scarring and in patients with general risk 
factors as diabetes, active smoking, chemotherapy, and 
morbid obesity.7 Furthermore, if infection and/or expo-
sure of mesh ensue in the event of being exposed due 
to dehiscence or breakdown of overlying skin, surgical 
removal is often required. Observation from previously 
published reports demonstrated the relatively high infec-
tion rate (6–22%) in chest wall reconstruction in noncon-
taminated defects with up to 42% requirement of removal 
of synthetic mesh.6 In this series, of extensive chest wall 
defects (mean, 511 cm2) in compromised surgical fields, 
Strattice ADM was used to substitute synthetic mesh to re-
sist infection. The general consensus accepted for chest 
wall skeletal reconstruction that we also applied in our 
series is that any defect less than 5 cm in size in any lo-
cation, and those up to 10 cm in size posteriorly do not 
need rigid reconstruction for functional reasons. On the 
other hand, posterior defects in proximity to the tip of 
the scapula and larger lesions mostly anterior and lateral 
are likely to produce paradoxical chest wall motion there-
fore requires rigid reconstruction.1,6,10,11 Four patients in 
our series required additional structural support with 
rigid skeletal reconstruction using titanium plates (Stra-
tos) due to the extent and location of the defects in the 
anterolateral chest wall region to maintain chest wall in-
tegrity. To date, there are few case reports demonstrating 
the use of Strattice in chest wall reconstruction.14,16,17 Al-
ternatively, other bioprosthetic meshes as Alloderm and 
Permacol in both human and animal models have shown 
to be efficacious in similar scenarios.7,12,13 The advantages 
of biological mesh materials over synthetic material have 
been reported, which includes superior handling proper-
ties, reduced visceral adhesions, resistance to infection, 
better integration into the autologous tissue due to host 
cell infiltration, and revascularization while maintaining 
structural integrity.7,13 In addition, bioprosthesis has bet-
ter tolerance to exposure due to tissue breakdown, hence 
can be managed conservatively rather than surgical ex-
tipiration.7,13,19 Despite the ability of both Alloderm and 
Strattice to become revascularized and resist infection, 
previous case reports have highlighted the superiority of 
porcine-derived over human-derived biological mesh in-
cluding less elasticity to avoid stretch, been harvested in 
larger and consistent sheets achieving coverage of larger 
defects with a single sheet.15,17,20 This was in concordance 
with our results, as 1 sheet was used per patient notwith-
standing that the defect sizes reconstructed in this series 
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were relatively larger from previously reported cases. The 
relatively longer follow-up (mean, 24.8 months) when 
compared with previous reports illustrated the durabil-
ity of the functional properties of a remodeled mature 
biologic scaffold in terms of strength and stretch. Dur-
ing the follow-up period, all patients showed satisfactory 
functional outcome assessed clinically and with pulmo-
nary function testes complimented with equally cosmetic 
satisfactory cosmetic outcomes. Hedgire et al.21 reported 
on significant enhancement of Alloderm Biologic Mesh 
Spacer in the abdomen and pelvis detected on follow-up 
multi detector CT scan through progressive rise in Houn-
sfield unit values. This has been attributed to the possi-
ble revascularization of the ADM as supported by other 
Fig. 1. a, large undifferentiated fungating necrotic soft-tissue sarcoma left chest wall in a 
53-year-old smoker male patient. B, ct scan defining the extent of the lesion with involvement 
of underlying ribs and intercostals space necessitating resection of ribs to achieve negative 
surgical margins; c, intraoperative photograph post en bloc tumor resection including 4 ribs 
demonstrating the skeletal defect exposing underlying thoracic viscera. D, intraoperative pho-
tograph showing reconstruction of the skeletal defect using Strattice aDM used with StRatOS 
bar. e, intraoperative photograph showing soft-tissue coverage achieved with lattissmus dorsi 
muscle flap and meshed skin graft. F, 10 Months postoperative photograph showing 1 × 2 cm 
distal wound dehiscence postradiotherapy. g, Postoperative photograph 3 weeks postdebride-
ment and secondary closure of the dehiscence area. note the full maturation of the graft.
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reports.22 In our study, this was also observed in the CT 
scan follow-up performed postoperatively in 4 patients, 
which revealed well-enhanced scar tissue denoting revas-
cularization and maturation providing stable coverage. 
Arguably other synthetic mesh materials would have been 
used; however, there would be an increased risk of infec-
tion of these synthetic meshes within this compromised 
surgical field and their intolerance for contamination and 
/or cutaneous exposure, which has been highlighted in 
other studies.7,8,14 Eventually, this would lead to detrimen-
tal consequences as a result of the requirement of mesh 
removal, which has been also highlighted in previous 
studies.6,7,14 In his case report, Brunbjerg et al.14 reported 
the use of Strattice successfully in chest wall reconstruc-
Fig. 2. a and B, Preoperative photograph showing radiation induced sarcoma of right upper chest wall in a 71-year-old female patient 
post breast cancer treatment. High risk factors included smoking, diabetes, previous radiotherapy, and previous chronic deep abscess 
(front-lateral view). c, ct scan defining the extent of the lesion with involvement of underlying ribs and intercostals space necessitating 
resection of ribs to achieve negative surgical margins. D, intraoperative photograph post en bloc tumor resection including 3 ribs demon-
strating the extent of skeletal and soft-tissue resection exposing underlying thoracic viscera, axillary neurovascular bundle and brachial 
plexus. e, intraoperative photograph showing reconstruction of the skeletal defect using nonrigid reconstruction with Strattice aDM only. 
F, intraoperative photograph postmicrovascular anastomosis of free MStRaM type i using the internal mammary vascular pedicle as re-
cipient vessels to provide soft-tissue coverage of the chest wall defect. g and H, 12 Months postoperative photograph showing complete 
survival of the flap with primary healing and restoration of chest wall anatomy (front-lateral view).
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tion in a patient with multiple recurrent breast cancer, 
chemotherapy, and radiotherapy requiring multiple chest 
wall resection and reconstruction with previous failure 
and extrusion of the polypropylene mesh. We previously 
reported the value of multidisciplinary thoracic oncoplas-
tic approach in the reduction of infection (2.8%) in the 
presence of synthetic prosthetic material in noncontami-
nated chest wall defects.3 Adopting the same approach in 
this relatively small cohort of high-risk patients, the perti-
nence of bioprosthetic mesh is seen to be associated with 
decreased incidence of SSI, less extrusion rate without any 
compromise of the chest wall stability that has also been 
supported by other studies.6,7,14 Observation from previ-
ously published reports demonstrated the importance of 
the proximate collaboration between several disciplines in 
managing these patients; however, it underscores the oc-
currence of the wound morbidity even in the presence of 
soft-tissue coverage for rigid reconstruction ranging from 
9% to 25%,1,8 whereas in other series, this relationship was 
not highlighted.9,23 The recruitment of well-vascularized 
soft tissue is paramount to provide coverage of the pros-
thesis, prevent infection, seal the pleural space, protect 
underlying viscera, obliterate dead space, contribute to 
structure integrity and healing, and enhance aesthetic 
outcome.1–3,7,24,25 A wide variety of flaps could be used in-
cluding loco-regional or free flaps depending on the site, 
size, and availability of tissues from donor sites and the 
available expertise.3,7,26 Soft-tissue coverage was performed 
in all patients in this series due to the extent of the cutane-
ous defects and to provide protection for the underlying 
Strattice and titanium plates. The majority of the patients 
required free flap including MSTRAM and TFL (5 of 8; 
62.5%) when loco-regional flaps deemed not feasible, ex-
tent of the resection and due to the logistics of positioning 
the patients to allow thoracic and reconstructive surgeons 
working simultaneously. The efficacy of the xenogeneic 
nature of biological mesh has been questionable in previ-
ous reports7,13,27,28; however, with the rapidly increasing use 
of porcine-derived ADM in several indications including 
breast, abdominal, head and neck, dural reconstruction 
and static reconstruction postfacial nerve paralysis over 
the last decade has demonstrated its advantages.8,29–33
The current literature is largely limited to case stud-
ies, and to the authors best knowledge, this would be the 
largest series from a single institute to be reported with 
long-term follow-up addressing the decreased incidence 
of SSI and durability of chest wall reconstruction with the 
use of Strattice ADM in high risk patients. However, the 
limitation for this study is the relatively low number of 
patients from a single institute mainly due to the rarity of 
these presentations, the lack of available control group 
for direct comparison, and the requirement of potential 
objective analysis comparing pre- and postsurgery chest 
wall biomechanics. This study is driven to evaluate the 
indications and functional outcomes in patients undergo-
ing chest wall reconstruction with bioprosthesis Strattice 
ADM, which would act as a safe alternative modality for 
chest wall reconstruction to resist infection in high risk 
patients with extensive defects. It should be considered 
as a valuable tool in the armamentarium of chest wall re-
construction.
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